<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Development and validation of a CFD model predicting the backfill process of a nuclear waste gallery
2
Development and Validation of a Checklist for Urban Health Service Centers in Terms of Health, Safety and Environmental Management
3
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: Application to the assessment of CYP2D6 activity in fibromyalgia patients
4
Development and validation of a chemiluminogenic method for the evaluation of antioxidant activity of hydrophilic and hydrophobic antioxidants Original Research Article
5
Development and validation of a Chinese version of the Falls Efficacy Scale International
6
Development and validation of a chiral HPLC method for rapid screening of allylic alcohol asymmetric epoxidation processes Original Research Article
7
Development and validation of a chiral liquid chromatographic method, based on Chiralpak® to quantify enantiomers of (±)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(−)-DRF 2725) to its antipode in plasma
8
Development and Validation of a Clinical Guideline for Reproductive Health in Natural Disasters: A Mixed Methods Study
9
Development and validation of a clinical prediction rule for major adverse outcomes in coronary bypass grafting
10
Development and Validation of a Clinical Score to Estimate the Probability of Coronary Artery Disease in Men and Women Presenting with Suspected Coronary Disease
11
Development and validation of a column-switching high-performance liquid chromatographic method for the determination of sanfetrinem in rat and dog plasma by direct injection
12
Development and validation of a combined temperature, water activity, pH model for bacterial growth rate of Lactobacillus curvatus
13
Development and validation of a compact thermal model for an aircraft compartment
14
Development and validation of a composite finite element with damping capability
15
Development and validation of a computer crash simulation model of an occupied adult manual wheelchair subjected to a frontal impact
16
Development and Validation of a Computer-based Decision-Making Task (CDMT) to Measure Decision-Making
17
Development and validation of a condenser three zones model
18
Development and validation of a confirmatory method for the determination of 12 non steroidal anti-inflammatory drugs in milk using liquid chromatography–tandem mass spectrometry
19
Development and validation of a confirmatory method for the determination of sulphonamides in milk by liquid chromatography with diode array detection Original Research Article
20
Development and validation of a convenient formula evaluating the value and applicability of medical literature in clinical practice
21
Development and validation of a coupled heat and mass transfer model for green roofs
22
Development and Validation of a Critical Language Pedagogy Literacy Scale in Iranian Universities
23
Development and validation of a cross-section interface for PARCS
24
Development and validation of a decigram-scale method for the separation of limonin from limonin glucoside by C-18 flash chromatography
25
Development and Validation of A Decision-Making Donor Conception Questionnaire in Iranian Infertile Couples
26
Development and Validation of a Decision-Making Stratification Algorithm to Optimize the Use of Rapid Diagnostic Testing for Patients with Staphylococcus Bacteremia
27
Development and validation of a depression scale for Asian adolescents
28
Development and Validation of a Derivative Spectrophotometric Method for Simultaneous Multicomponent Determination of Levodopa, Carbidopa and Entacapone
29
Development and validation of a desiccant wheel model calibrated under transient operating conditions
30
Development and validation of a device for the measurement of free air space and air permeability in solid waste
31
Development and validation of a dimensional variation measurement set—application to the plaster setting
32
Development and validation of a dimensional variation measurement set—application to the plaster setting
33
Development and validation of a direct enantiomeric separation of pregabalin to support isolated perfused rat kidney studies
34
Development and Validation of a Direct qPCR Method for the Detection of Pork Adulteration in Processed Meat Products
35
Development and validation of a Disaster Management Metamodel (DMM)
36
Development and Validation of a Disease Severity Scoring Model for Pediatric Sepsis
37
Development and Validation of a Disease Severity Scoring Model for Pediatric Sepsis
38
Development and Validation of a Dish-Based Iranian Food Frequency Questionnaire: A Protocol Study
39
Development and validation of a disk solid phase extraction and gas chromatography–mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat
40
Development and Validation of a Dissolution Test Method for Artemether and Lumefantrine in Tablets
41
Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry
42
Development and validation of a dried blood spot—LC–APCI–MS assay for estimation of canrenone in paediatric samples
43
Development and validation of a duplex real-time PCR assay for the simultaneous detection of three mustard species (Sinapis alba, Brassica nigra and Brassica juncea) in food
44
Development and validation of a duplex real-time PCR method for the simultaneous detection of celery and white mustard in food
45
Development and validation of a fast and sensitive chromatographic assay for all-trans-retinol and tocopherols in human serum and plasma using liquid–liquid extraction
46
Development and validation of a fast and sensitive UPLC–MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity
47
Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography–electrospray-tandem mass spectrometry
48
Development and validation of a fast high pressure liquid chromatography method for the analysis of lignocellulosic biomass hydrolysis and fermentation products
49
Development and validation of a fast high-performance liquid chromatography method for the determination of microencapsulated pyrethroid pesticides Original Research Article
50
Development and validation of a fast method for determination of free glycerol in biodiesel by capillary electrophoresis
51
Development and validation of a fast monoclonal based disequilibrium enzyme-linked immunosorbent assay for the detection of triphenylmethane dyes and their metabolites in fish Original Research Article
52
Development and Validation of a Fast PCR-Based Detection Method for Pathogenic Isolates of the Citrus Black Spot Fungus, Guignardia citricarpa
53
Development and validation of a fast quantitative method for plasma dimethylarginines analysis using liquid chromatography–tandem mass spectrometry
54
Development and validation of a fast reactor core burnup code – FARCOB
55
Development and Validation of A Fast, Simple and Specific Stability Indicating RP-HPLC Method for Determination of Dexpanthenol in Eye Gel Formulation
56
Development and validation of a finite element model for water – CO2 coaxial gas-coolers
57
Development and validation of a flux-based stoichiometric model for enhanced biological phosphorus removal metabolism
58
Development and Validation of a Food Frequency Questionnaire for Assessing Dietary Calcium in Children
59
Development and validation of a free-piston engine generator numerical model
60
Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System
61
Development and validation of a gas chromatographic–mass spectrometric method for quantitative determination of perphenazine in rabbit plasma after sublingual administration
62
Development and validation of a gas chromatographic–mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparatio
63
Development and validation of a gas chromatography/ion trap-mass spectrometry method for simultaneous quantification of cocaine and its metabolites benzoylecgonine and norcocaine: Application to the study of cocaine metabolism in human primary cultured re
64
Development and validation of a gas chromatography-mass spectrometry assay for hair analysis of amphetamine, methamphetamine and methylenedioxy derivatives
65
Development and validation of a gas chromatography–mass spectrometry method for determination of deoxynivalenol and its metabolites in human urine
66
Development and validation of a gas chromatography–mass spectrometry method for the determination of isoimperatorin in rat plasma and tissue: Application to the pharmacokinetic and tissue distribution study
67
Development and validation of a gas chromatography–mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study
68
Development and validation of a gas chromatography–negative chemical ionization tandem mass spectrometry method for the determination of ethyl glucuronide in hair and its application to forensic toxicology
69
Development and validation of a gas chromatography-tandem mass spectrometry analytical method for the monitoring of ultra-traces of priority substances in surface waters
70
Development and validation of a GC/MS method for determination of phenolic xenoestrogens in aquatic samples
71
Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms
72
Development and Validation of a GC-FID Method for Diagnosis of Methylmalonic Acidemia
73
Development and validation of a GC–MS method for rapid determination of galanthamine in Leucojum aestivum and Narcissus ssp.: A metabolomic approach
74
Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks
75
Development and validation of a general-purpose ASIC chip for the control of switched reluctance machines
76
Development and validation of a global database of lakes, reservoirs and wetlands
77
Development and validation of a grouping method for pesticides analysed in foodstuffs
78
Development and validation of a heart-cutting liquid chromatography–mass spectrometry method for the determination of process-related substances in cetirizine tablets Original Research Article
79
Development and validation of a high performance liquid chromatography assay for 17α-methyltestosterone in fish feed
80
Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting
81
Development and validation of a High Performance Liquid Chromatography-Diode Array Detection method for the determination of aging markers in tequila
82
Development and validation of a high performance liquid chromatography–tandem mass spectrometry for the determination of etodolac in human plasma
83
Development and validation of a high throughput and robust LC–MS/MS with electrospray ionization method for simultaneous quantitation of diltiazem and its two metabolites in human plasma: Application to a bioequivalence study
84
Development and validation of a highly rapid and sensitive LC–MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma – Application to a pharmacokinetic study in rats
85
Development and validation of a highly sensitive and robust LC–MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: Application to a bioequivalence study
86
Development and validation of a highly sensitive economic enzymeimmunoassay for prolactin determination in blood plasma of mithun (Bos frontalis) and its application during milk let down and cyclicity
87
Development and validation of a highly sensitive ELISA for the determination of pharmaceutical indomethacin in water samples
88
Development and validation of a highly sensitive gas chromatographic–mass spectrometric screening method for the simultaneous determination of nanogram levels of fentanyl, sufentanil and alfentanil in air and surface contamination wipes
89
Development and validation of a highly sensitive LC–MS/MS method for organic cation transporter (OCT) substrate tetraethylammonium (TEA) in rabbits
90
Development and validation of a high-performance liquid chromatographic method for the analysis of antioxidative phenolic compounds in fennel using a narrow bore reversed phase C18 column
91
Development and validation of a high-performance liquid chromatographic method for the analysis of antioxidative phenolic compounds in fennel using a narrow bore reversed phase C18 column Original Research Article
92
Development and validation of a high-performance liquid chromatographic method for the determination of clomazone residues in surface water
93
Development and validation of a high-performance liquid chromatographic method for the determination of γ-hydroxybutyric acid in rat plasma
94
Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile
95
Development and validation of a high-performance liquid chromatographic method using fluorimetric detection for the determination of the diarrhetic shellfish poisoning toxin okadaic acid without chlorinated solvents
96
Development and Validation of a High-Performance Liquid Chromatography Method for the Determination of Astaxanthin in Fish Samples; Application of the Method in Identification of Fake Salmon Marketed in Iran
97
Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma
98
Development and Validation of a High-Performance Liquid Chromatography Method With UV Detection for Determination of 1-(2-phenylethyl)-5- (quinaldin-4-yl) Biuret in Rat Plasma
99
Development and validation of a high-performance liquid chromatography–mass spectrometric assay for the determination of 17α-hydroxyprogesterone caproate (17-OHPC) in human plasma
100
Development and validation of a high-performance liquid chromatography–mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma
101
Development and validation of a high-performance liquid chromatography–mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma
102
Development and validation of a high-performance liquid chromatography–tandem mass spectrometric method for quantification of daunorubicin in rat plasma
103
Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay for the determination of sanfetrinem in human plasma
104
Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay quantifying olaparib in human plasma
105
Development and validation of a high-performance liquid chromatography–tandem mass spectrometry for the determination of penciclovir in human plasma: Application to a bioequivalence study
106
Development and validation of a high-precision capillary electrophoresis method for main component assay of ragaglitazar
107
Development and validation of a high-resolution mass-spectrometry–based method to study the long-term stability of natural and synthetic glucocorticoids in faeces
108
Development and validation of a high-throughput double solid phase extraction–liquid chromatography–tandem mass spectrometry method for the determination of tetrodotoxin in human urine and plasma
109
Development and validation of a high-throughput high-performance liquid chromatographic assay for the determination of caffeine in food samples using a monolithic column Original Research Article
110
Development and validation of a high-throughput membrane bioreactor (HT-MBR)
111
Development and validation of a high-throughput method for the quantitative analysis of d-amphetamine in rat blood using liquid chromatography/MS3 on a hybrid triple quadrupole-linear ion trap mass spectrometer and its application to a pharmacokinetic stu
112
Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction–liquid chromatography–tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma
113
Development and validation of a hospital screening tool for malnutrition: the short nutritional assessment questionnaire (SNAQ©)
114
Development and Validation of a HPLC Method for Determination of Pefloxacin in Tablet and Human Plasma
115
Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments
116
Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation
117
Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design
118
Development and validation of a HPLC method for the quantification of baculovirus particles
119
Development and validation of a HPLC method for the quantitation of ochratoxins in plasma and raw milk
120
Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma
121
Development and validation of a HPLC-UV method for determination of Proscillaridin A in Drimia maritima
122
Development and validation of a hydrophilic interaction chromatography-mass spectrometry assay for taurine and methionine in matrices rich in carbohydrates
123
Development and validation of a hydrophilic interaction chromatography–tandem mass spectrometry method with on-line polar extraction for the analysis of urinary nucleosides. Potential application in clinical diagnosis
124
Development and validation of a hydrophilic interaction liquid chromatographic method for determination of aromatic amines in environmental water
125
Development and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometry method for determination of isoniazid in human plasma
126
Development and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometry method for the quantification of lipid-related extracellular metabolites in Saccharomyces cerevisiae
127
Development and Validation of a Kinetic Model for Enzymatic Saccharification of Lignocellulosic Biomass
128
Development and validation of a knowledge test for health professionals regarding lifestyle modification
129
Development and validation of a knowledge, attitude, and practice questionnaire on nutrition‑related cancer prevention for Iranian women
130
Development and validation of a laminar flame speed correlation for the CFD simulation of hydrogen-enriched gasoline engines
131
Development and validation of a lateral flow assay for the detection of crustacean protein in processed foods
132
Development and validation of a LC/MS/MS method for quantification of nobiliside A in rat plasma
133
Development and validation of a LC/MS/MS method for quantifying the next generation calcineurin inhibitor, voclosporin, in human whole blood
134
Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum
135
Development and validation of a LC-ESI–MS/MS method for the determination of swertiamarin in rat plasma and its application in pharmacokinetics
136
Development and validation of a LC–MS/MS method for homocysteine thiolactone in plasma and evaluation of its stability in plasma samples
137
Development and validation of a LC–MS/MS method for the determination of clebopride and its application to a pharmacokinetics study in healthy Chinese volunteers
138
Development and validation of a LC–MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
139
Development and validation of a LC–MS/MS method for the determination of viaminate in human plasma
140
Development and validation of a LC–MS/MS method for the quantification of the regioisomers of dihydroxybutylether in human plasma
141
Development and validation of a lead emission inventory for the Greater Cairo area
142
Development and validation of a leaf wetness duration model using a fuzzy logic system
143
Development and validation of a liquid chromatographic method for Casiopeina IIgly® in rat plasma
144
Development and validation of a liquid chromatographic method for Casiopeina IIIi® in rat plasma
145
Development and validation of a liquid chromatographic method for determination of lacidipine residues on surfaces in the manufacture of pharmaceuticals
146
Development and validation of a liquid chromatographic method for in vitro mupirocin quantification in both skin layers and percutaneous penetration studies
147
Development and validation of a liquid chromatographic method for the analysis of capreomycin sulfate and its related substances
148
Development and validation of a liquid chromatographic method for the determination of hydroxymethylfurfural and alpha-ketoglutaric acid in human plasma Original Research Article
149
Development and validation of a liquid chromatographic method for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites in plasma and saliva
150
Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the determination of salidroside in rat plasma: Application to the pharmacokinetics study
151
Development and validation of a liquid chromatographic–electrospray tandem mass spectrometric multiresidue method for anthelmintics in milk
152
Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of eleven coccidiostats in milk
153
Development and validation of a liquid chromatographic–tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine
154
Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma: Stable isotope labeled internal standard does not always compensate for matrix effects
155
Development and validation of a liquid chromatographic–tandem mass spectrometric method for the determination of caffeic acid phenethyl ester in rat plasma and urine
156
Development and validation of a liquid chromatographic–tandem mass spectrometric method for the determination of galantamine in human heparinised plasma
157
Development and validation of a liquid chromatographic–tandem mass spectrometric method for the determination of pibutidine in human urine
158
Development and validation of a liquid chromatography and tandem mass spectrometry method for determination of roscovitine in plasma and urine samples utilizing on-line sample preparation
159
Development and validation of a liquid chromatography isotope dilution mass spectrometry method for the reliable quantification of alkylphenols in environmental water samples by isotope pattern deconvolution
160
Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord
161
Development and validation of a liquid chromatography method for simultaneous determination of three process-related impurities: yeastolates, triton X-100 and methotrexate
162
Development and validation of a liquid chromatography tandem mass spectrometry method for the analysis of β-agonists in animal feed and drinking water
163
Development and validation of a liquid chromatography/atmospheric pressure photoionization-tandem mass spectrometric method for the analysis of mycotoxins subjected to commission regulation (EC) No. 1881/2006 In cereals
164
Development and validation of a liquid chromatography/electrospray ionization time-of-flight mass spectrometry method for relative and absolute quantification of steroidal alkaloids in Fritillaria species
165
Development and validation of a liquid chromatography/linear ion trap mass spectrometry method for the quantitative determination of deoxynivalenol-3-glucoside in processed cereal-derived products
166
Development and validation of a liquid chromatography/mass spectrometry method for pharmacokinetic studies of OZ78, a fasciocidal drug candidate
167
Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of d-amphetamine and diphenhydramine in beagle dog plasma and its application to a pharmacokinetic study
168
Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic
169
Development and validation of a liquid chromatography/tandem mass spectrometry method for quantitative determination of amoxicillin in bovine muscle
170
Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma
171
Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: Application to an explorative study
172
Development and validation of a liquid chromatography–atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in
173
Development and validation of a liquid chromatography–atmospheric pressure photoionization–mass spectrometry method for the quantification of alprazolam, flunitrazepam, and their main metabolites in haemolysed blood
174
Development and validation of a liquid chromatography–electrosprayionization mass spectrometric method for the determination of dexamethasone in sheep plasma
175
Development and validation of a liquid chromatography–electrosprayionization mass spectrometric method for the determination of dexamethasone in sheep plasma Original Research Article
176
Development and validation of a liquid chromatography–fluorescence–mass spectrometry method to measure glyphosate and aminomethylphosphonic acid in rat plasma
177
Development and validation of a liquid chromatography–mass spectrometric method for the determination of DPC 423, an antithrombotic agent, in rat and dog plasma
178
Development and validation of a liquid chromatography–mass spectrometry (LC–MS) assay for the determination of the anti-cancer agent N-[2-(dimethylamino)ethyl]-2,6-dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide (SN 28049)
179
Development and validation of a liquid chromatography–mass spectrometry assay for the determination of opiates and cocaine in meconium
180
Development and validation of a liquid chromatography–mass spectrometry assay for the determination of pyronaridine in human urine
181
Development and validation of a liquid chromatography–mass spectrometry method for the determination of verticinone in rat plasma and its application to pharmacokinetic study
182
Development and validation of a liquid chromatography–mass spectrometry method for the quantitation of naltrexone and 6β-naltrexol in guinea pig plasma
183
Development and validation of a liquid chromatography–tandem mass spectrometric assay for Eplerenone and its hydrolyzed metabolite in human plasma
184
Development and validation of a liquid chromatography–tandem mass spectrometric assay for pitavastatin and its lactone in human plasma and urine
185
Development and validation of a liquid chromatography—tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma
186
Development and validation of a liquid chromatography–tandem mass spectrometric method for the determination of α-methyltyrosine in human plasma
187
Development and validation of a liquid chromatography–tandem mass spectrometric method for the quantification of 5-thio-d-glucose in rat and human plasma
188
Development and validation of a liquid chromatography–tandem mass spectrometry assay for determination of raloxifene and its metabolites in human plasma
189
Development and validation of a liquid chromatography–tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
190
Development and validation of a liquid chromatography–tandem mass spectrometry assay for the simultaneous quantitation of microcystin-RR and its metabolites in fish liver
191
Development and validation of a liquid chromatography–tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: Application to a pharmacokinetic study
192
Development and validation of a liquid chromatography–tandem mass spectrometry for the determination of Kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: Application to a pharmacokinetic study
193
Development and validation of a liquid chromatography–tandem mass spectrometry method for quantification of decitabine in rat plasma
194
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of ARQ 501 (β-lapachone) in plasma and tumors from nu/nu mouse xenografts
195
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of goserelin in rabbit plasma
196
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of phenylephrine in human plasma and its application to a pharmacokinetic study
197
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of pyridostigmine bromide from guinea pig plasma
198
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
199
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of xanthinol in human plasma and its application in a bioequivalence study of xanthinol nicotinate tablets
200
Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of opiorphin in human saliva
201
Development and validation of a liquid chromatography–tandem mass spectrometry method for the separation of conjugated and unconjugated 17α- and 17β-boldenone in urine sample Original Research Article
202
Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous determination of nine corticosteroid residues in bovine liver samples Original Research Article
203
Development and validation of a liquid chromatography-ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285·HCl [(2S,3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage form
204
DEVELOPMENT AND VALIDATION OF A LOCALIZATION FRAMEWORK FOR WIRELESS SENSOR NETWORKS
205
Development and validation of a low-cost, portable and wireless gait assessment tool
206
Development and validation of a material-labeling method for powder process characterization using X-ray computed tomography
207
Development and Validation of a Mathematical Model for Ventilation Rate in Crop Protection Structures
208
Development and validation of a mathematical model to describe the growth of Pseudomonas spp. in raw poultry stored under aerobic conditions
209
Development and validation of a measure of children’s automatic thoughts: the children’s automatic thoughts scale
210
Development and validation of a measure of emotional intelligence
211
Development and validation of a measure of intercultural adjustment potential in Japanese sojourners: the Intercultural Adjustment Potential Scale (ICAPS)
212
Development and validation of a measure of justice perception in the frame of Fairness theory – Fuzzy approach
213
Development and Validation of a Measure of Self-Regulated Capacity in Learning the Grammar of English as a Foreign Language
214
Development and validation of a measure of the impact of epilepsy on a young person’s quality of life: Glasgow epilepsy outcome scale for young persons (GEOS-YP)
215
Development and validation of a measure to assess head start childrens appraisals of teacher support
216
Development and validation of a measure to assess head start childrenʹs appraisals of teacher support
217
Development and validation of a measurement instrument for studying supply chain management practices
218
Development and validation of a mechanistic model to predict solid particle erosion in multiphase flow
219
Development and validation of a method aimed at estimating building performance parameters
220
Development and validation of a method for active drug identification and content determination of ranitidine in pharmaceutical products using near-infrared reflectance spectroscopy: A parametric release approach
221
Development and validation of a method for air-quality and nuisance odors monitoring of volatile organic compounds using multi-sorbent adsorption and gas chromatography/mass spectrometry thermal desorption system
222
Development and validation of a method for analysis of “dioxin-like” PCBs in environmental samples from the steel industry
223
Development and Validation of a Method for Densitometric Analysis of Berberine in Herbal Extract and Polyherbal Formulation
224
Development and validation of a method for determination of corticosteroids in pig fat using liquid chromatography–tandem mass spectrometry
225
Development and validation of a method for determination of trace levels of alkylphenols and bisphenol A in atmospheric samples
226
Development and validation of a method for determining pesticides in groundwater from complex overlapped HPLC signals and multivariate curve resolution
227
Development and validation of a method for fipronil residue determination in ovine plasma using 96-well plate solid-phase extraction and gas chromatography–tandem mass spectrometry
228
Development and validation of a method for quantitative determination of econazole nitrate in cream formulation by capillary zone electrophoresis
229
Development and validation of a method for simultaneous analysis of the boar taint compounds indole, skatole and androstenone in pig fat using liquid chromatography–multiple mass spectrometry
230
Development and validation of a method for the confirmation of halofuginone in chicken liver and eggs using electrospray tandem mass spectrometry
231
Development and validation of a method for the detection and confirmation of biomarkers of exposure in human urine by means of restricted access material-liquid chromatography–tandem mass spectrometry
232
Development and validation of a method for the determination of a therapeutic peptide with affinity for the human B1 receptor in human plasma using HPLC-MS/MS
233
Development and validation of a method for the determination of EDTA in non-alcoholic drinks by HPLC
234
Development and validation of a method for the determination of EDTA in non-alcoholic drinks by HPLC
235
Development and validation of a method for the determination of sulfonamides in animal feed by modified QuEChERS and LC–MS/MS analysis
236
Development and validation of a method for the determination of trace alkylphenols and phthalates in the atmosphere Original Research Article
237
Development and validation of a method for the purity determination of (3β,20R)-4,4-dimethylcholesta-8,14,24-trien-3-ol(FF-MAS) in pharmaceutical products containing recombinant human albumin
238
Development and validation of a method for the quantitation of Δ9tetrahydrocannabinol in oral fluid by liquid chromatography electrospray–mass-spectrometry
239
Development and validation of a method for the simultaneous extraction and separate measurement of oxytetracycline, florfenicol, oxolinic acid and flumequine from marine sediments
240
Development and validation of a methodology for dose calculation in electron beam irradiation of complex-shaped foods Original Research Article
241
Development and Validation of a Methodology for Intracellular pH Measurements of Hybridoma Cells under Bioreactor Culture Conditions
242
Development and Validation of a Methodology for Intracellular pH Measurements of Hybridoma Cells under Bioreactor Culture Conditions
243
Development and validation of a methodology for uranium radiochronometry reference material preparation Original Research Article
244
Development and validation of a methodology to challenge the adaptive comfort model
245
Development and Validation of a Micellar Capillary Electrophoresis Method for Determination of IFNβ-1b in Lyophilized Formulation of a Biosimilar Product
246
Development and validation of a micellar liquid chromatography-based method to quantify melamine in swine kidney
247
Development and validation of a microchannel evaporator model for a CO2 air-conditioning system
248
Development and validation of a microemulsion electrokinetic chromatography method for patulin quantification in commercial apple juice
249
Development and validation of a micromethod for fast quantification of 5-n-alkylresorcinols in grains and whole grain products
250
Development and validation of a microsomal online cytochrome P450 bioreactor coupled to solid-phase extraction and reversed-phase liquid chromatography
251
Development and validation of a minimal growth medium for recycling Chlorella vulgaris culture
252
Development and Validation of a Model for HSE Management Performance Assessment Based on the Resilience Engineering Approach (A Case Study in a Car Manufacturing Company)
253
Development and Validation of a Model for Predicting Productivity Based on Psychosocial Factors in Administrative Staff; The Mediating Role of Physical and Mental Health
254
Development and validation of a model for the chemical kinetics of graphite oxidation
255
Development and validation of a model to predict enzymatic activity during storage of cultivated mushrooms (Agaricus bisporus spp.) Original Research Article
256
Development and validation of a modified Hybrid-III six-year-old dummy model for simulating submarining in motor-vehicle crashes
257
Development and validation of a molecular predictive model to describe the growth of Listeria monocytogenes in vacuum-packaged chilled pork
258
Development and Validation of a Monolingual Glossary of Terms Used by Cockfighters
259
development and validation of a moral intelligence measure for the adolescent children of veterans
260
Development and validation of a multi-analyte method for the detection of anabolic steroids in bovine urine with liquid chromatography–tandem mass spectrometry
261
Development and validation of a multiclass method for the analysis of antibiotic residues in eggs by liquid chromatography–tandem mass spectrometry
262
Development and validation of a multiclass method for the determination of veterinary drug residues in chicken by ultra high performance liquid chromatography–tandem mass spectrometry
263
Development and validation of a multicriteria indicator for the assessment of objective aesthetic impact of wind farms
264
Development and validation of a multi-residue liquid chromatography–tandem mass spectrometry confirmatory method for eleven coccidiostats in eggs Original Research Article
265
Development and validation of a multi-residue method for pesticide determination in honey using on-column liquid–liquid extraction and liquid chromatography–tandem mass spectrometry
266
Development and validation of a multiresidue method for the analysis of polybrominated diphenyl ethers, new brominated and organophosphorus flame retardants in sediment, sludge and dust
267
Development and validation of a multi-residue method for the detection of a wide range of hormonal anabolic compounds in hair using gas chromatography–tandem mass spectrometry Original Research Article
268
Development and validation of a multi-residue method for the determination of pesticides in honeybees using acetonitrile-based extraction and gas chromatography–tandem quadrupole mass spectrometry
269
Development and validation of a multi-zone combustion model for performance and nitric oxide formation in syngas fueled spark ignition engine
270
Development and validation of a music performance anxiety inventory for gifted adolescent musicians
271
Development and validation of a nanometer manipulation and measurement system for biomechanical testing of single macro-molecules
272
Development and Validation of a Near-Infrared Method for the Quantitation of Caffeine in Intact Single Tablets
273
Development and Validation of a New Adenosine-Independent Index of Stenosis Severity From Coronary Wave–Intensity Analysis: Results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) Study
274
Development and validation of a new analytical method for the determination of 1,4-dichlorobenzene in honey by gas chromatography–isotope dilution mass spectrometry after steam-distillation Original Research Article
275
Development and validation of a new approach for computer-aided long bone fracture reduction using unilateral external fixator
276
Development and Validation of a New Capillary Electrophoresis Assay for Monitoring of Atenolol Photodegradation Product in Non-aqueous Solution
277
DEVELOPMENT AND VALIDATION OF A NEW EXPERIMENTAL METHOD TO IDENTIFY DAMPING MATRICES OF A DYNAMIC SYSTEM
278
Development and validation of a new fluorescence-based bioassay for aquatic macrophyte species Original Research Article
279
Development and validation of a new Fourier transform infrared spectrometric method for the quantification of urea in creams and ointments Original Research Article
280
Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples
281
Development and validation of a new LC–MS/MS method for the simultaneous determination of six major ergot alkaloids and their corresponding epimers. Application to some food and feed commodities
282
Development and validation of a new method for determination of topiramate in bulk and pharmaceutical formulation using high performance liquid chromatography-UV detection after pre-column derivatizat
283
Development and validation of a new method for determining humidification and dehumidification needs
284
Development and validation of a new method of 3-dimensional assessment of glenoid and humeral component position after total shoulder arthroplasty
285
Development and validation of a new qualitative ELISA screening for multiresidue detection of sulfonamides in food and feed
286
Development and validation of a new reference cylindrical gear for pitch measurement
287
Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor
288
Development and Validation of a New Risk Score for Infection with Coronavirus (Ri.S.I.Co) Obtained from Treating Coronavirus Disease (COVID-19) Patients on the Field
289
Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles
290
Development and Validation of a New RP-HPLC Method for the Determination of Aprepitant in Solid Dosage Forms
291
Development and validation of a new simple Healthy Meal Index for canteen meals
292
Development and validation of a new soot formation model for gas turbine combustor simulations
293
Development and validation of a new tool measuring nurses self-reported professional competence—The nurse professional competence (NPC) Scale
294
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
295
Development and Validation of a Nomogram for Predicting the Mortality after Penetrating Traumatic Brain Injury
296
Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer
297
Development and validation of a nonaqueous capillary electrophoretic method for the enantiomeric purity determination of a synthetic intermediate of new 3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans using a single-isomer anionic cyclodextrin derivative and an
298
Development and validation of a non-aqueous reversed-phase high-performance liquid chromatographic method for the determination of four chemical UV filters in suncare formulations
299
Development and Validation of a Noninvasive Method to Determine Arterial Pressure and Vascular Compliance
300
Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of sulfamethoxazole and trimethoprim in co-trimoxazole tablets
301
Development and validation of a novel derivatization method for the determination of lactate in urine and saliva by liquid chromatography with UV and fluorescence detection
302
Development and validation of a novel Digital Image Analysis method for fluidized bed Particle Image Velocimetry
303
Development and Validation of a Novel Method to Derive Central Aortic Systolic Pressure From the Radial Pressure Waveform Using an N-Point Moving Average Method
304
Development and validation of a novel portable slip simulator
305
Development and validation of a novel rating system for scoring standing foot posture: The Foot Posture Index
306
Development and validation of a novel real-time PCR method for the detection of celery (Apium graveolens) in food
307
Development and validation of a numerical model to predict the penetration of a glycerophosphate-based corrosion inhibitor through concrete
308
Development and validation of a nylon6 nanofibers mat-based SPE coupled with HPLC method for the determination of docetaxel in rabbit plasma and its application to the relative bioavailability study
309
Development and validation of a patient-report measure of fatigue associated with depression
310
Development and validation of a PCR–RFLP test to identify African Rhipicephalus (Boophilus) ticks
311
Development and Validation of a Persian Version of Dichotic Emotional Word Test
312
Development and validation of a plasma assay for acyclovir using high-performance capillary electrophoresis with sample stacking
313
Development and validation of a postpartum depression risk score in delivered women, Iran
314
Development and validation of a pre-column reversed phase liquid chromatographic method with fluorescence detection for the determination of primary phenethylamines in dietary supplements and phytoextracts
315
Development and validation of a prediction model for strokes after coronary artery bypass grafting
316
Development and validation of a predictive model for the growth of Vibrio parahaemolyticus in post-harvest shellstock oysters
317
Development and validation of a pressurised liquid extraction liquid chromatography–electrospray–tandem mass spectrometry method for β-lactams and sulfonamides in animal feed
318
Development and validation of a pressurized liquid extraction liquid chromatography–tandem mass spectrometry method for perfluorinated compounds determination in fish
319
Development and validation of a probabilistic second-order exposure assessment model for Escherichia coli O157:H7 contamination of beef trimmings from Irish meat plants
320
Development and validation of a probe allowing accurate and continuous monitoring of location of squamo-columnar junction
321
Development and validation of a processing map for Aermet100 steel
322
Development and Validation of a Prognostic Nomogram Based on Fibrosis-4 Index to Predict 3-Month Mortality in Patients with Hepatic Encephalopathy
323
Development and validation of a Q-sort measure of identity processing style: The identity processing style Q-sort
324
Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
325
Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry
326
Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography–tandem mass spectrometry
327
Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography–tandem mass spectrometry
328
Development and validation of a quantitative gas chromatography–mass spectrometry method for the detection of endogenous androgens in mouse urine
329
Development and validation of a quantitative LC–tandem MS assay for hexadeca-4,7,10,13-tetraenoic acid in human and mouse plasma
330
Development and validation of a quantitative liquid chromatography tandem mass spectrometry assay for pristimerin in rat plasma
331
Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography–tandem mass spectrometry
332
Development and validation of a quantitative method for the selective determination of tin species in tin octoate by differential pulse polarography
333
Development and Validation of a Quantitative Research Literacy Questionnaire
334
Development and validation of a quantitative spectrophotometric method to detect the amount of carbon monoxide in treated tuna fish
335
Development and validation of a quasi-dimensional combustion model for SI engines fuelled by HCNG with variable hydrogen fractions
336
Development and validation of a quasi-dimensional model for methanol and ethanol fueled SI engines
337
Development and validation of a quasi-Gaussian plume model for the transport of botanical spores
338
Development and validation of a QuEChERS based liquid chromatography tandem mass spectrometry method for the determination of multiple mycotoxins in spices
339
Development and Validation of a Questionnaire for Emotional Divorce Measurement: A Mixed Research on Family Mental Health Context
340
Development and validation of a questionnaire for anxiety and depression in Pakistan
341
Development and Validation of a Questionnaire for Preliminary Assessment of Heat Stress at Workplace
342
Development and Validation of a Questionnaire to Measure Quality of Life in Caregivers of Patients with Schizophrenia and Affective Disorders (SAC-QoL)
343
Development and Validation of a Questionnaire to Predict Intention to Comply to Iron Supplement during Pregnancy
344
Development and validation of a questionnaire to test knowledge and practices of dietitians regarding dietary supplements
345
Development and validation of a radial variable geometry turbine model for transient pulsating flow applications
346
Development and validation of a Radiance model for a translucent panel
347
Development and validation of a rapid 96-well format based liquid–liquid extraction and liquid chromatography–tandem mass spectrometry analysis method for ondansetron in human plasma
348
Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1′-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry
349
Development and validation of a rapid and sensitive high-performance liquid chromatography–mass spectroscopy assay for determination of 17-(allylamino)-17-demethoxygeldanamycin and 17-(amino)-17-demethoxygeldanamycin in human plasma
350
Development and validation of a rapid and sensitive liquid chromatography–tandem mass spectrometry method for benvitimod quantification in human plasma
351
Development and validation of a rapid and sensitive UPLC–MS/MS method for determination of total docetaxel from a lipid microsphere formulation in human plasma
352
Development and validation of a rapid and wide-scope qualitative screening method for detection and identification of organic pollutants in natural water and wastewater by gas chromatography time-of-flight mass spectrometry
353
Development and validation of a rapid assay based on liquid chromatography–tandem mass spectromtetry for determining macrolide antibiotic residues in eggs
354
Development and validation of a rapid capillary zone electrophoresis method for determining charge variants of mAb
355
Development and Validation of a Rapid Derivative Spectrophotometric Method for Determination of Tropicamide in Eye Drops
356
Development and validation of a rapid headspace gas chromatography–mass spectrometry method for the determination of diethyl ether and acetone residues in Tween extracts of shellfish intended for mouse bioassay for diarrhoetic toxins
357
Development and validation of a rapid high-performance liquid chromatography-tandem mass spectrometry method for the determination of WJ-38, a novel aldose reductase inhibitor, in rat plasma and its application to a pharmacokinetic study
358
Development and validation of a rapid HPLC- fluorescence method for simultaneous determination of venlafaxine and its major metabolites in human plasma
359
Development and validation of a rapid HPLC method for simultaneous analysis of budesonide and its novel synthesized hemiesters in colon specific formulations
360
Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma
361
Development and validation of a rapid HPLC method for the determination of cefdinir in beagle dog plasma integrated with an automatic on-line solid-phase extraction following protein precipitation in the 96-well plate format
362
Development and validation of a rapid HPLC method for the determination of five banned fat-soluble colorants in spices using a narrow-bore monolithic column
363
Development and validation of a rapid HPLC method for the simultaneous determination of triethylenetetramine and its two main metabolites in human serum
364
Development and validation of a rapid method for the determination and confirmation of 10 nitroimidazoles in animal plasma using liquid chromatography tandem mass spectrometry
365
Development and validation of a rapid multiresidue method for pesticide determination using gas chromatography–mass spectrometry: A realistic case in vineyard soils
366
Development and validation of a rapid real-time PCR based method for the specific detection of Salmonella on fresh meat
367
Development and validation of a rapid ultra high pressure liquid chromatographic method for the determination of methylxanthines in herbal infusions
368
Development and validation of a rapid ultra-high performance liquid chromatography diode array detector method for Vitex agnus-castus
369
Development and validation of a rapid, sensitive liquid chromatography–tandem mass spectrometry method using electrospray ionization for quantitation of centchroman in rat plasma and its application to preclinical pharmacokinetic study
370
Development and Validation of a Real-Time PCR Assay for Identification of a Common Agrotis Species: Agrotis segetum (Lepidoptera: Noctuidae
371
Development and validation of a real-time PCR assay specific for Clostridium estertheticum and C. estertheticum-like psychrotolerant bacteria
372
Development and validation of a real-time PCR method for the simultaneous detection of black mustard (Brassica nigra) and brown mustard (Brassica juncea) in food
373
Development and validation of a reduced combined biodiesel–diesel reaction mechanism
374
Development and Validation of a Reversed Phase HPLCMethod for Simultaneous Determination of Amlodipineand Telmisartan in Pharmaceutical Dosage Form
375
Development and Validation of a Reversed Phase HPLCMethod for Simultaneous Determination of Amlodipineand Telmisartan in Pharmaceutical Dosage Form
376
Development and validation of a reversed phase liquid chromatographic method for separation and determination of related-substances of modafinil in bulk drugs
377
Development and validation of a reversed-phase fluorescence HPLC method for determination of bucillamine in human plasma using pre-column derivatization with monobromobimane
378
Development and validation of a reversed-phase high-performance liquid chromatographic method for quantification of peptide dendrimers in human skin permeation experiments
379
Development and validation of a reversed-phase high-performance liquid chromatographic method for the determination of ethyl-3-(N-n-butyl-N-acetyl)aminopropionate in an insect repellent semi-solid formulation
380
Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms
381
Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations
382
Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations Original Research Article
383
Development and validation of a reversed-phase ion-pair liquid chromatography method for the determination of magnesium ascorbyl phosphate and melatonin in cosmetic creams Original Research Article
384
Development and validation of a reversed-phase liquid chromatographic method for analysis of D4T (Stavudine) in rat plasma
385
Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma Original Research Article
386
Development and validation of a reversed-phase liquid chromatography method for the quantitative determination of carboxylic acids in industrial reaction mixtures
387
Development and Validation of a Reverse-Phase HPLC Method for Determination of Some Water-Soluble Vitamins and Preservatives in Pharmaceutical Forms
388
Development and validation of a reverse-phase HPLC with fluorescence detector method for simultaneous determination of CZ48 and its active metabolite camptothecin in mouse plasma
389
Development and Validation of a RP- HPLC Method for Simultaneous Estimation of Rosiglitazone and Metformin in Bulk and Tablet Dosage Form
390
Development and validation of a RP-HPLC method for quantification of isoflavone aglycones in hydrolyzed soy dry extracts
391
DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF NAPROXEN AND RANITIDINEHYDROCHLORIDE
392
Development and Validation of a RP-HPLC Method for the Simultaneous Determination of Rifampicin and a Flavonoid Glycoside - A Novel Bioavailability Enhancer of Rifampicin
393
Development and validation of a RP-HPLC method with fluorescence detection for simultaneous determination of 10-methoxycamptothecin and its metabolite 10-hydroxycamptothecin in rat plasma
394
Development and validation of a sample stabilization strategy and a UPLC–MS/MS method for the simultaneous quantitation of acetylcholine (ACh), histamine (HA), and its metabolites in rat cerebrospinal fluid (CSF)
395
Development and validation of a sandwich ELISA for the determination of potentially allergenic lupine in food
396
Development and validation of a scale to measure Latino parenting strategies related to children’s obesigenic behaviors. The parenting strategies for eating and activity scale (PEAS)
397
Development and Validation of a Scale to Measure Violence against Women among Myanmar Migrant Women in Thailand
398
Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme
399
Development and validation of a screening procedure of microalgae for biodiesel production: Application to the genus of marine microalgae Nannochloropsis
400
Development and validation of a screening questionnaire for present or past (hypo)manic episodes based on DSM-IV-TR criteria
401
Development and validation of a selective and robust LC–MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: Application to a clinical pharmacokinetic study
402
Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass
403
Development and validation of a selective and sensitive LC–MS/MS method for determination of cycloserine in human plasma: Application to bioequivalence study
404
Development and Validation of a Self-Efficacy Scale with Writing and Social Factors
405
Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography–tandem mass spectrometry
406
Development and validation of a semi-empirical model for the estimation of particulate matter in diesel engines
407
Development and validation of a Semi-quantitative food frequency questionnaire among older people in north of Iran
408
Development and validation of a sensitive and rapid non-aqueous LC–ESI-MS/MS method for measurement of diosgenin in the plasma of normal and hyperlipidemic rats: A comparative study
409
Development and validation of a sensitive and selective LC–MS/MS method for the determination of trans δ-veniferin, a resveratrol dehydrodimer, in rat plasma and its application to pharmacokinetics and bioavailability studies
410
Development and validation of a sensitive and selective UHPLC–MS/MS method for simultaneous determination of both free and total eicosapentaeonic acid and docosahexenoic acid in human plasma
411
Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization
412
Development and validation of a Sensitive bioanalytical method for the quantitative estimation of Pantoprazole in human plasma samples by LC–MS/MS: Application to bioequivalence study
413
Development and validation of a sensitive enantiomeric separation method for new single enantiomer drug levornidazole by CD-capillary electrophoresis
414
Development and validation of a sensitive enzyme immunoassay for surveillance of Cry1Ab toxin in bovine blood plasma of cows fed Bt-maize (MON810) Original Research Article
415
Development and validation of a sensitive gas chromatography–ammonia chemical ionization mass spectrometry method for the determination of tabun enantiomers in hemolysed blood and plasma of different species
416
Development and validation of a sensitive HPLC method for the quantification of HI-6 in guinea pig plasma and evaluated in domestic swine
417
Development and validation of a sensitive HPLC–ESI-MS/MS method for the direct determination of glucosamine in human plasma
418
Development and validation of a sensitive LC/MS/MS method for the simultaneous determination of naloxone and its metabolites in mouse plasma
419
Development and validation of a sensitive LC–MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma
420
Development and validation of a sensitive LC-MS/MS method for simultaneous quantification of sinotecan and its active metabolite in human blood
421
Development and validation of a sensitive LC–MS/MS method for the determination of fenoterol in human plasma and urine samples
422
Development and validation of a sensitive LC–MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma
423
Development and validation of a sensitive liquid chromatographic−tandem mass spectrometric method for the determination of cromolyn sodium in human plasma
424
Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule
425
Development and validation of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of exemestane in human plasma
426
Development and validation of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of raddeanin A in rat plasma and its application to a pharmacokinetic study
427
Development and validation of a sensitive liquid chromatography–tandem mass spectrometry method for the determination of paeoniflorin in rat brain and its application to pharmacokinetic study
428
Development and validation of a sensitive solid phase extraction/hydrophilic interaction liquid chromatography/mass spectrometry method for the accurate determination of glucosamine in dog plasma
429
Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC–MS/MS) for determination of risedronate concentrations in human plasma
430
Development and validation of a sensitive U-HPLC–MS/MS method with electrospray ionization for quantitation of ranolazine in human plasma: Application to a clinical pharmacokinetic study
431
Development and validation of a sensitive ultra performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context
432
Development and validation of a sequential-injection method with chemiluminescence detection for the high throughput assay of the total antioxidant capacity of wines
433
Development and validation of a series of three-dimensional finite element models of the equine metacarpus
434
Development and validation of a short form of the Chinese version of the State Anxiety Scale for Children
435
Development and validation of a short form of the self-efficacy measurement tool for Iranian patients with myocardial infarction
436
Development and validation of a short, consumer-oriented nutrition knowledge questionnaire
437
Development and validation of a simple analytical method for the determination of 2,4,6-trichloroanisole in wine by GC–MS
438
Development and Validation of a Simple and Rapid HPLC Method for the Evaluation of Pesticide Residues in Plasma Samples of Farmers; Application in Toxicological and Risk Assessment Studies
439
Development and validation of a simple and sensitive high performance liquid chromatographic method for the simultaneous determination of anastrozole, bicalutamide, tamoxifen, and their synthetic impurities
440
Development and validation of a simple and sensitive HPLC–UV method for the determination of captopril in human plasma using a new derivatizing reagent 2-naphthyl propiolate
441
Development and validation of a simple and sensitive method for quantification of levodopa and carbidopa in rat and monkey plasma using derivatization and UPLC–MS/MS
442
Development and validation of a simple capillary zone electrophoresis method for the analysis of kanamycin sulfate with UV detection after pre-capillary derivatization
443
Development and validation of a simple determination of urine metabolites (oxalate, citrate, uric acid and creatinine) by capillary zone electrophoresis
444
Development and Validation of a Simple Equation to Fat Mass and Percentage of Body Fat in Children and Adolescents
445
Development and validation of a simple exercise test score for use in women with symptoms of suspected coronary artery disease
446
Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples
447
Development and validation of a simple mineral dust source inventory suitable for modelling in North Central China
448
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: Potential impact on cardiac catheterization use in the United States and Canada
449
Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles
450
Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery
451
Development and validation of a simple stability-indicating high performance liquid chromatographic method for the determination of miconazole nitrate in bulk and cream formulations
452
Development and validation of a simple thermo-desorption technique for mercury speciation in soils and sediments
453
Development and validation of a simplified online cooling load prediction strategy for a super high-rise building in Hong Kong
454
Development and Validation Of A Simulation Model For Heat Pump Water Heater
455
Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma
456
Development and validation of a socioeconomic status short-form questionnaire (SES-SQ)
457
Development and validation of a solid phase micro-extraction–gas chromatography–mass spectrometry method for the determination of furan in baby-food
458
Development and validation of a solid-phase extraction and gas chromatography–tandem mass spectrometry method for the determination of isopropyl-9H-thioxanthen-9-one in carton packaged milk
459
Development and validation of a solid-phase extraction method coupled to high-performance liquid chromatography with ultraviolet-diode array detection for the determination of sulfonylurea herbicide residues in bovine milk samples
460
Development and validation of a solid-phase extraction method coupled to liquid chromatography with fluorescence detection for the determination of fluoroquinolone residues in powdered infant formulae: Application to the analysis of samples from the Spani
461
Development and validation of a spatial snow-glide model
462
Development and validation of a spatial snow-glide model
463
Development and Validation of A Spectrofluorimetric Determination of Calf Thymus DNA Using a Terbium-Danofloxacin Probe
464
Development and Validation of a Spike Detection and Classification Algorithm Aimed at Implementation on Hardware Devices
465
Development and Validation of a Stability Indicating HPLC Assay Method for Determination of Warfarin Sodium in Tablet Formulation
466
Development and validation of a stability indicating HPLC method for the analysis of lornoxicam in powder for injection
467
Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation
468
Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation
469
Development and validation of a stability indicative HPLC–PDA method for kaurenoic acid in spray dried extracts of Sphagneticola trilobata (L.) Pruski, Asteraceae
470
Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms
471
Development and validation of a stability-indicating high-performance liquid chromatographic assay for ketoprofen topical penetrating gel
472
Development and Validation of a Stability-indicating HPLC Method for Determination of Insulin Detemir and Preservatives in their Injection Products
473
Development and validation of a stability-indicating reversed-phase high performance liquid chromatography method for assay of betamethylepoxide and estimation of its related compounds
474
Development and validation of a stability-indicating reversed-phase high performance liquid chromatography method for NPC 1161C, a novel 8-aminoquinoline anti-malarial drug
475
Development and Validation of a Stability-Indicating Reversed-Phase HPLC Method for Simultaneous Estimation of Rosuvastatin and Ezetimibe from Their Combination Dosage Forms
476
Development and Validation of a Stability-Indicating RP-HPLC Method for Rapid Determination of Doxycycline in Pharmaceutical Bulk and Dosage Forms
477
Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Determination of Paracetamol, Tramadol HCl and Domperidone in a Combined Dosage Form
478
Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms
479
Development and validation of a stability-indicative agar diffusion assay to determine the potency of linezolid in tablets in the presence of photodegradation products
480
Development and validation of a stereoselective liquid chromatography–tandem mass spectrometry assay for quantification of S- and R-metoprolol in human plasma
481
Development and validation of a stroke recognition tool
482
Development and validation of a sub-minute capillary zone electrophoresis method for determination of nitrate and nitrite in baby foods
483
Development and validation of a survey for quality of life assessment by owners of healthy dogs
484
Development and validation of a technique for merging satellite derived aerosol optical depth from SeaWiFS and MODIS
485
Development and validation of a technoeconomic analysis tool for early-stage evaluation of bio-based chemical production processes
486
Development and Validation of a Terbium-Sensitized LuminescenceAnalytical Method for Deferiprone
487
Development and validation of a terrestrial biotic ligand model predicting the effect of cobalt on root growth of barley (Hordeum vulgare)
488
Development and validation of a tertiary simulation model for predicting the potential growth of Salmonella typhimurium on cooked chicken
489
Development and validation of a theoretical model for diesel spray penetration
490
Development and validation of a three-dimensional curvilinear model for the study of fluxes through the North Channel of the Irish Sea
491
Development and validation of a three-dimensional kinematic model for the McPherson steering and suspension mechanisms
492
Development and validation of a three-dimensional morphodynamic modelling system for non-cohesive sediments
493
Development and validation of a three-dimensional ring-based structural tyre model
494
Development and Validation of a Tool for Assessing Barriers to Participation in Team Sports for Women with Physical-Mobility Disabilities
495
Development and Validation of a Tool for Measuring Knowledge, Attitude,and Behavior Regarding Unused Household Medicine Management
496
Development and Validation of a Total Coronary Heart Disease Risk Score in Type 2 Diabetes Mellitus
497
Development and Validation of a Training-Embedded Speaking Assessment Rating Scale: A Multifaceted Rasch Analysis in Speaking Assessment
498
Development and validation of a transition boiling model for RELAP5/MOD3 reflood simulation Original Research Article
499
Development and Validation of a Two-Dimensional Scale to Measure Family Functions
500
Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines
501
Development and validation of a UPLC–ELSD method for fast simultaneous determination of five bile acid derivatives in Calculus Bovis and its medicinal preparations
502
Development and Validation of a Voice Disorder Outcome Profile for an Indian Population
503
Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making
504
Development and validation of a web-based protocol for management of sports-related concussion
505
Development and validation of a wheel wear and rolling contact fatigue damage model
506
Development and validation of a zonal model — POMA
507
Development and validation of aboveground biomass estimations for four Salix clones in central New York
508
Development and Validation of Academic Self-regulated Learning Questionnaire (ASLQ)
509
Development and Validation of Activity Based Learning Scale among Teachers
510
Development and Validation of Aducanumab by Bioanalytical Method Using Liquid Chromatography-Tandem Mass Spectroscopy
511
DEVELOPMENT AND VALIDATION OF ALFUS: AN IRRADIATION BEHAVIOR ANALYSIS CODE FOR METALLIC FAST REACTOR FUELS
512
Development and validation of an accurate and rapid LC-ESI-MS/MS method for the simultaneous quantification of aflatoxin B1, B2, G1 and G2 in lotus seeds
513
Development and validation of an acute biotic ligand model (BLM) predicting cobalt toxicity in soil to the potworm Enchytraeus albidus
514
Development and validation of an acute biotic ligand model (BLM) predicting cobalt toxicity in soil to the potworm Enchytraeus albidus
515
Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV
516
Development and validation of an analytical method for the determination of arsenic, cadmium and lead content in powdered infant formula by means of quadrupole Inductively Coupled Plasma Mass Spectrometry
517
Development and validation of an analytical method for the determination of semicarbazide in fresh egg and in egg powder based on the use of liquid chromatography tandem mass spectrometry Original Research Article
518
Development and validation of an analytical method for the separation and determination of major bioactive curcuminoids in Curcuma longa rhizomes and herbal products using non-aqueous capillary electrophoresis
519
Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography–tandem mass spectrometry
520
Development and validation of an assay method for the determination of trifluoroacetic acid in a cyclosporin-like drug
521
Development and validation of an assessment sheet for all-ceramic crown preparations: A methodological study
522
Development and Validation of an Authorial Identity Model and Questionnaire: A Factor Analytic Approach
523
Development and validation of an automated and marker-free CT-based spatial analysis method (CTSA) for assessment of femoral hip implant migration
524
Development and validation of an automated monitoring system for oxygenated volatile organic compounds and nitrile compounds in ambient air
525
Development and validation of an automatic thermal imaging process for assessing plant water status
526
Development and Validation of an Awareness Assessment Instrument of Safe Work for Laboratory Staff
527
Development and validation of an easy multiresidue method for the determination of multiclass pesticide residues using GC–MS/MS and LC–MS/MS in olive oil and olives
528
Development and validation of an eating norms inventory. Americans’ lay-beliefs about appropriate eating
529
Development and Validation of an Echocardiographic Model for Predicting Progression of Discrete Subaortic Stenosis in Children
530
Development and validation of an efficient automated method for the analysis of 300 pesticides in foods using two-dimensional liquid chromatography–tandem mass spectrometry
531
Development and Validation of an EFL Teachers’ Quality Assurance Questionnaire
532
Development and validation of an EI-GC/MS method for the determination of sertraline and its major metabolite desmethyl-sertraline in blood
533
Development and validation of an electromagnetic model of the active control system of MHD modes in RFX-mod
534
Development and Validation of an Electronic Scale for Sexual Violence Experiences in Iranian Women
535
Development and validation of an ELISA for metolachlor mercapturate in urine Original Research Article
536
Development and validation of an ELISA for the quantification of pig Major Acute phase Protein (Pig-MAP)
537
Development and validation of an ELISA for the quantification of pig Major Acute phase Protein (Pig-MAP)
538
Development and Validation of an Emergency Department Screening and Referral Protocol for Victims of Domestic Violence, , ,
539
Development and validation of an empirical free energy function for calculating protein–protein binding free energy surfaces Original Research Article
540
Development and validation of an enantioselective HPLC–UV method using Chiralpak AD-H to quantify (+)- and (−)-torcetrapib enantiomers in hamster plasma—application to a pharmacokinetic study
541
Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma
542
Development and Validation of an English Language Teacher Professional Identity Scale (ELTPIS)
543
Development and validation of an environmentally friendly attenuated total reflectance in the mid-infrared region method for the determination of ethanol content in used engine lubrication oil
544
Development and validation of an enzyme-linked immunosorbent assay for the detection of circulating antibodies raised against growth hormone as a consequence of rbST treatment in cows Original Research Article
545
Development and validation of an enzyme-linked immunosorbent assay for the quantification of cytochrome 3A4 in human liver microsomes
546
Development and validation of an e-teachers’ autonomy-support scale: A SEM approach
547
Development and validation of an expert-based habitat suitability model to support boreal caribou conservation
548
Development and validation of an extensive growth and growth boundary model for psychrotolerant Lactobacillus spp. in seafood and meat products
549
Development and validation of an extraction method for the determination of pro-inflammatory eicosanoids in human plasma using liquid chromatography–tandem mass spectrometry
550
Development and Validation of an HPLC Method for Determination of Amifostine and/or Its Metabolite (WR-1065) in Human Plasma Using OPA Derivatization and UV Detection
551
Development and Validation of an HPLC Method for the Analysis of Sirolimus in Drug Products
552
Development and validation of an HPLC method for the determination of alk(en)ylresorcinols using rapid ultrasound-assisted extraction of mango peels and rye grains
553
Development and validation of an HPLC method for the determination of dibenzoylmethane in rat plasma and its application to the pharmacokinetic study
554
Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs Original Research Article
555
Development and validation of an HPLC method for the determination of six penicillin and three amphenicol antibiotics in gilthead seabream (Sparus Aurata) tissue according to the European Union Decision 2002/657/EC
556
Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples
557
Development and validation of an HPLC method for the simultaneous quantification of indole-3-carbinol acetate, indole-3-carbinol, and 3,3′-diindolylmethane in mouse plasma, liver, and kidney tissues
558
Development and validation of an HPLC-DAD method for quantification of bornesitol in extracts from Hancornia speciosa leaves after derivatization with p-toluenesulfonyl chloride
559
Development and validation of an HPLC–FLD method for milbemectin quantification in dog plasma
560
Development and validation of an HPLC-FLD method for rapid determination of histamine in skipjack tuna fish (Katsuwonus pelamis)
561
Development and validation of an HPLC-method for determination of free and bound phenolic acids in cereals after solid-phase extraction
562
Development and validation of an HPLC-method for the determination of alkaloids in the stem bark extract of Nauclea pobeguinii
563
Development and validation of an HPLC–MS/MS method to determine clopidogrel in human plasma. Use of incurred samples to test back-conversion
564
Development and validation of an HPLC-PDA method for the determination of myrsinoic acid B in the extracts of Rapanea ferruginea Mez
565
Development and validation of an HPLC-UV method for determination of iohexol in human plasma
566
Development and validation of an HPLC-UV method for iodixanol quantification in human plasma
567
Development and validation of an HPLC–UV method for the quantification of carbamazepine in rabbit plasma
568
Development and validation of an HPLC–UV method for the quantification of carbamazepine in rabbit plasma
569
Development and Validation of an HPTLC - Densitometric Method for Determination of Levodopa in seeds of Mucuna pruriens and its capsule dosage form
570
Development and validation of an immunochromatographic assay for rapid detection of sulfadiazine in eggs and chickens
571
Development and validation of an immunochromatographic assay for rapid multi-residues detection of cephems in milk Original Research Article
572
Development and validation of an improved liquid chromatographic method for the analysis of dirithromycin
573
Development and validation of an improved liquid chromatography–mass spectrometry method for the determination of pemetrexed in human plasma
574
Development and validation of an improved method for the analysis of vancomycin by liquid chromatography: Selectivity of reversed-phase columns towards vancomycin components
575
Development and validation of an individual based Daphnia magna population model: The influence of crowding on population dynamics
576
Development and validation of an individual based Daphnia magna population model: The influence of crowding on population dynamics
577
Development and Validation of an Instrument Exploring Factors Challenging Iranian Graduate Student-Teachers
578
Development and Validation of an Instrument to Access the Lecturers’ Performance in the Education and Teaching Duties
579
Development and Validation of an Instrument to Assess Child Dietary Fat Intake
580
Development and Validation of an Instrument to Evaluate English Language Teachers' Lesson Planning Self-concept
581
Development and validation of an instrument to measure organizational cultures’ support of Business Process Management
582
Development and validation of an instrument to measure user perceived service quality of information presenting Web portals
583
Development and validation of an instrument to measure user perceived service quality of information presenting Web portals
584
Development and validation of an instrument to measure user perceived service quality of mHealth
585
Development and validation of an insulated isothermal polymerase chain reaction assay for the rapid detection of Mycoplasma synoviae
586
Development and Validation of an Intact Cell Assay for Protein Tyrosine Phosphatases Using Recombinant Baculoviruses
587
Development and validation of an integer linear programming model for the lecturer-to-course assignment problem
588
Development and Validation of an International English Big-Five Mini-Markers
589
DEVELOPMENT AND VALIDATION OF AN INTERNATIONALLY RELIABLE SHORT-FORM OF THE POSITIVE AND NEGATIVE AFFECT SCHEDULE (PANAS)
590
Development and validation of an internet use attitude scale
591
Development and validation of an inventory to measure stressful events: Findings from a population-based survey
592
Development and Validation of an Ion Chromatography Method for Quantification of Ammonium Ions in STEALTH® Liposomes
593
Development and validation of an ion pair HPLC method for gemcitabine and 2′,2′-difluoro-2′-deoxyuridine determination Original Research Article
594
Development and validation of an ion-pair chromatographic method for simultaneous determination of trans- and cis-urocanic acid in fish samples
595
Development and validation of an LC/MS/MS assay for mycophenolic acid in human peripheral blood mononuclear cells
596
Development and validation of an LC–ESI/MS/MS method with precolumn derivatization for the determination of betulin in rat plasma
597
Development and validation of an LC–ESI–MS/MS method for the determination of nitidine chloride in rat plasma
598
Development and validation of an LC–MS/MS based method for quantification of 25 hydroxyvitamin D2 and 25 hydroxyvitamin D3 in human serum and plasma
599
Development and validation of an LC–MS/MS method for determination of methanesulfonamide in human urine
600
Development and validation of an LC–MS/MS method for determination of the L-type voltage-gated calcium channel/NMDA receptor antagonist NGP1-01 in mouse serum
601
Development and validation of an LC–MS/MS method for pharmacokinetic study of methoxyamine in phase I clinical trial
602
Development and validation of an LC–MS/MS method for quantification of cyclic guanosine 3′,5′-monophosphate (cGMP) in clinical applications: A comparison with a EIA method
603
Development and validation of an LC–MS/MS method for the determination of tolvaptan in human plasma and its application to a pharmacokinetic study
604
Development and validation of an LC–MS/MS method for the quantification of ephedrines in urine
605
Development and validation of an LC–MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma
606
Development and validation of an LC–MS/MS/MS method for the quantification of fluoroquinolones in several matrices from treated turkeys
607
Development and validation of an MMPI-based Sensation Seeking Scale
608
Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC–HRMS for doping control Original Research Article
609
Development and Validation of an RP-HPLC Method for Simultaneous Analysis of Ofloxacin and Ornidazole in Tablets
610
Development and validation of an RP-HPLC method for the analysis of anthraquinones in noni fruits and leaves
611
Development and validation of an ultra high performance liquid chromatography tandem mass spectrometry method for determination of 10 cephalosporins and desacetylcefapirin in milk
612
Development and validation of an ultra high performance liquid chromatography tandem mass spectrometry method for simultaneous determination of sulfonamides, quinolones and benzimidazoles in bovine milk
613
Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasma
614
Development and validation of an ultra-high performance liquid chromatography tandem mass spectrometry method for quantifying thyreostats in urine without derivatisation
615
Development and validation of an ultra-high-performance liquid chromatography coupled to time-of-flight mass spectrometry method to quantify benzoic acid and long-chain monocarboxylic acids (C12–C28) in atmospheric aerosols
616
Development and validation of an UPLC method for determination of content uniformity in low-dose solid drugs products using the design space approach
617
Development and Validation of Analytical Method for Fluconazole and Fluconazole Related Compounds (A, B, and C) in Capsule Formulations by HPLC with UV Detection
618
Development and Validation of Analytical Method for Losartan-Copper Complex Using UV-Vis Spectrophotometry
619
Development and validation of analytical method for simultaneous estimation of sofosbuvir and velpatasvir by RP-HPLC method in pharmaceutical dosage form
620
Development and validation of analytical methods for ethyl carbamate in various fermented foods
621
Development and validation of analytical methods: C.M. Riley and T.W. Rosanske (Eds.), Pergamon, Oxford, 1996 (ISBN 0-08-042792-8). x+352 pp. price US $ 88.00
622
Development and Validation of Assessment Instrument for Community-Engaged Scholarship of Medical University Faculty
623
Development and Validation of Assessment Practice Inventory for Teacher Educators
624
Development and validation of atmospheric dispersion: computer program using tritium air concentrations in the environment around heavy water reactor power plants
625
Development and validation of atmospheric gene flow model for assessing environmental risks from transgenic corn crops
626
Development and Validation of Attitude toward Gestational Surrogacy Scale in Iranian Infertile Couples
627
Development and validation of automatic HS-SPME with a gas chromatography-ion trap/mass spectrometry method for analysis of volatiles in wines
628
Development and Validation of Bioanalytical Method for Simultaneous Estimation of Nebivolol Enantiomers in Human Plasma Using Liquid Chromatography-tandem Mass Spectrometry
629
Development and validation of bioanalytical methods for Imidafenacin (KRP-197/ONO-8025) and its metabolites in human plasma by liquid chromatography–tandem mass spectrometry
630
Development and Validation of Biocriteria Using Benthic Macroinvertebrates for North Carolina Estuarine Waters
631
Development and validation of biomarker classifiers for treatment selection
632
Development and validation of canopy reflectance-based crop coefficient for potato
633
Development and validation of cardiac patient competence questionnaire, Iranian version
634
Development and validation of chemometrics-assisted spectrophotometry and micellar electrokinetic chromatography for the determination of four-component pharmaceuticals Original Research Article
635
Development and validation of competencies for medical librarians in Pakistan. Unpublished M.Phil. thesis, University of the Punjab, Lahore, 2011. [Abstract]
636
Development and validation of conservative-mechanistic and best estimate approaches to quantifying mass fractions of agglomerated debris
637
Development and validation of control materials for the measurement of vitamin D3 in selected US foods
638
Development and validation of control materials for the measurement of vitamin D3 in selected US foods
639
Development and Validation of Conventional and Quantitative Polymerase Chain Reaction Assays for the Detection of Storage Rot Potato Pathogens, Phytophthora erythroseptica, Pythium ultimum and Phoma foveata
640
Development and Validation of COVID-19 Stress Scale (CSS) in an Iranian Non-clinical Population
641
Development and validation of cytokine quantitative, real time RT-PCR assays for characterization of Asian elephant immune responses
642
Development and validation of cytokine quantitative, real time RT-PCR assays for characterization of Asian elephant immune responses
643
Development and validation of Decisional Balance and Temptations measures for Bulgarian adolescent smokers
644
Development and Validation of Disordered Eating Behavior Scale: Identification, Prevalence, and Difference with Clinically Diagnosed Eating Disorders
645
Development and Validation of Dummies and Human ModelsUsed in Crash Test
646
Development and validation of efficient stable isotope dilution LC–HESI–MS/MS method for the verification of β-lyase metabolites in human urine after sulfur mustard exposure
647
Development and Validation of Emotion Regulation Strategies in Germophobia Questionnaire in Iran
648
Development and validation of ethylenethiourea determination in foods using methanol-based extraction, solid-phase extraction cleanup and LC–MS/MS
649
Development and validation of evaluation indicators for a consortium of institutional repositories: A case study of dcollection
650
Development and validation of extraction methods for determination of zinc and arsenic speciation in soils using focused ultrasound Application to heavy metal study in mud and soils
651
Development and validation of extraction methods for determination of zinc and arsenic speciation in soils using focused ultrasound: Application to heavy metal study in mud and soils Original Research Article
652
Development and validation of fast duplex real-time PCR assays based on SYBER Green florescence for detection of bovine and poultry origins in feedstuffs
653
Development and validation of fast Real-Time PCR assays for species identification in raw and cooked meat mixtures
654
Development and validation of fish-based, multimetric indices for assessing the ecological health of Western Australian estuaries
655
Development and Validation of Food and Nutrition Literacy Assessment Tool for Iranian High‑school Graduates and Youth
656
Development and Validation of Food Frequency Questionnaire (FFQ) for Estimation of the Dietary Polyphenol Intake Among Elderly Individuals in Klang Valley
657
Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI)
658
Development and Validation of Gas Chromatography-Mass Spectrometric Method for the Determination of Epoxidized Soybean Oil in Foods Stored in Glass Jars with Metal Lids
659
Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models
660
DEVELOPMENT AND VALIDATION OF GUI BASED INPUT FILE GENERATION CODE FOR RELAP
661
Development and validation of heat and mass transfer models for freeze-drying of vegetable slices Original Research Article
662
Development and Validation of Heminested RT-PCR and qRT-PCR Assays for Comprehensive Detection of Rabies Virus in the Suspected Rabid Brain and Saliva Samples
663
Development and validation of high liquid performance chromatography-tandem mass spectrometry method for simultaneous determination of geniposidic acid and aucubin in rat plasma for pharmacokinetic study after oral administration of Du-zhong tea extract
664
Development and validation of high performance liquid chromatographic method for analysis of clozapine
665
Development and Validation of High Performance Liquid Chromatographic Method for the Simultaneous Determination of Ceftazidime and Sulbactam in Spiked Plasma and Combined Dosage form-Zydotam
666
DEVELOPMENT AND VALIDATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR ANALYSIS OF SIBUTRAMINE HYDROCHLORIDE AND ITS IMPURITY
667
DEVELOPMENT AND VALIDATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR QUANTIFICATION OF RELATED SUBSTANCES IN CLARITHROMYCIN POWDER FOR AN ORAL SUSPENSION DOSAGE FORM
668
Development and validation of highly selective and robust method for simultaneous estimation of pioglitazone, hydroxypioglitazone and metformin in human plasma by LC–MS/MS: Application to a pharmacokinetic study
669
Development and validation of highly sensitive method for determination of misoprostol free acid in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study
670
Development and validation of high-throughput liquid chromatography–tandem mass spectrometric method for simultaneous quantification of Clopidogrel and its metabolite in human plasma
671
Development and validation of high-throughput liquid chromatography–tandem mass spectrometric method for simultaneous quantification of loratadine and desloratadine in human plasma
672
Development and Validation of HOSHRA Index for Occupational Safety and Health Risk Assessment in Hospitals
673
Development and validation of HPLC method for determination of clotrimazole and its two degradation products in spray formulation
674
Development and Validation of HPLC Method for Determination of Crocetin, a constituent of Saffron, in Human Serum Samples
675
Development and validation of HPLC method for determination of salicin in poplar buds: Application for screening of counterfeit propolis
676
Development and Validation of HPLC Method for Simultaneous Quantification of Prifinium Bromide/Paracetamol Combination in Pharmaceutical Formulations
677
Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate
678
Development and validation of HPLC method for the resolution of drug intermediates: dl-3-Phenyllactic acid, dl-O-acetyl-3-phenyllactic acid and (±)-mexiletine acetamide enantiomers
679
Development and Validation of HPLC Method for theSimultaneous Determination of Insecticides (Carbofuranand Fipronil) in its Technicaland Granular Formulation
680
Development and validation of HPLC method to measure active amines in plant food supplements containing Citrus aurantium L
681
Development and validation of HPLC methods for enantioseparation of mirtazapine enantiomers at analytical and semipreparative scale using polysaccharide chiral stationary phases Original Research Article
682
Development and validation of HPLC–ICP-MS method for the determination inorganic Cr, As and Sb speciation forms and its application for Pławniowice reservoir (Poland) water and bottom sediments variability study
683
Development and Validation of IndirectVisible Spectrophotometric Method for Doxepin and Dothiepinin Pureandthe Tablet Dosage Forms
684
Development and validation of Iranian children’s participation assessment scale
685
Development and Validation of Iranian EFL Learners’ Preference for Anxiety Reducing Strategies Questionnaire
686
Development and validation of Islamic quality of life questionnaire
687
Development and Validation of Islamic Questionnaire of Spiritual Intelligence
688
Development and validation of isomer specific RP-HPLC method for quantification of cefpodoxime proxetil
689
Development and Validation of KOLB 4.0 Learning Style Questionnaire
690
Development and validation of laboratory microcosms for anionic surfactant biodegradation by riverine biofilms
691
Development and Validation of Language Assessment Literacy Scale for High School EFL Teachers: A Mixed Methods Approach
692
DEVELOPMENT AND VALIDATION OF LC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ROSIGLITAZONE MALEATE AND GLIMEPIRIDE IN PHARMACEUTICAL DOSAGE FORM
693
Development and validation of LC methods with visible detection using pre-column derivatization and mass detection for the assay of voglibose
694
Development and validation of LC–ESI-MS method for sensitive, accurate and rapid determination of UC-781 in New Zealand white rabbit plasma
695
Development and validation of LC–MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine
696
Development and validation of LC–MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices
697
DEVELOPMENT AND VALIDATION OF LC-MS/MS METHOD FOR QUALITY CONTROL OF MEMANTINE HYDROCHLORIDE TABLET FORMULATION
698
Development and validation of LC–MS/MS method for quantitative determination of (−)-securinine in mouse plasma
699
Development and validation of LC–MS/MS methods for the determination of mirabegron and its metabolites in human plasma and their application to a clinical pharmacokinetic study
700
Development and validation of liquid chromatographic method for the determination of lycopene in plasma Original Research Article
701
Development and validation of liquid chromatography–mass spectrometry method for the determination of telmisartan in human plasma Original Research Article
702
Development and validation of liquid chromatography–tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma
703
Development and validation of mathematical model for aerobic composting process
704
Development and Validation of Measures of Psychosocial Factors Influencing Fat- and Fiber-Related Dietary Behavior
705
Development and validation of measures of social phobia scrutiny fear and social interaction anxiety
706
Development and validation of method for analysis of some ototoxic solvents in saliva matrix by headspace gas chromatography/mass spectrometry
707
Development and validation of method for heterocyclic compounds in wine: Optimization of HS-SPME conditions applying a response surface methodology
708
Development and validation of methods for the trace determination of PCBs in biological matrices
709
Development and validation of methods for the trace determination of phthalates in sludge and vegetables
710
Development and validation of Midwifery Vocational Perception Scale
711
Development and validation of model for estimating temperature within maize ear
712
Development and validation of moisture movement model for vacuum cooling of cooked meat Original Research Article
713
Development and validation of near infrared microscopy spectral libraries of ingredients in animal feed as a first step to adopting traceability and authenticity as guarantors of food safety
714
Development And Validation Of Negative Self-Image Inventory
715
Development and validation of new disease-specific measures of somatization and comorbidity in IBS
716
Development and validation of new methods for the determination of melatonin and its oxidative metabolites by high performance liquid chromatography and capillary electrophoresis, using multivariate optimization
717
Development and validation of numerical indexes integrating enzyme activities of soils
718
Development and validation of numerical indexes integrating enzyme activities of soils
719
Development and validation of numerical model of steel fiber reinforced concrete for high-velocity impact
720
Development and validation of online models with parameter estimation for a building zone with VAV system
721
Development and Validation of Parent Abuse Scale (Girl-Mother Version)
722
Development and Validation of Parenting Style Scale
723
DEVELOPMENT AND VALIDATION OF PCR, PLS, AND TLC DENSITOMETRIC METHODS FOR THE SIMULTANEOUS DETERMINATION OF VITAMINS B1, B6 AND B12 IN PHARMACEUTICAL FORMULATIONS
724
Development and Validation of Potentiometric Ion Selective Screen Printed Electrode for Sensitive Determination of Linagliptin in Pure Form and in Pharmaceutical Formulation; Application to Dissolution Testing
725
Development and validation of prediction algorithms for major depressive episode in the general population
726
Development and validation of preschool children’s well-being questionnaire
727
Development and validation of puma (Felis concolor) cytokine and lentivirus real-time PCR detection systems
728
Development and validation of puma (Felis concolor) cytokine and lentivirus real-time PCR detection systems
729
Development and Validation of Ramadan Fasting Basic Information and Nutritional Habits Questionnaire
730
DEVELOPMENT AND VALIDATION OF REACTION WHEEL DISTURBANCE MODELS: EMPIRICAL MODEL
731
Development and validation of rear impact computer simulation model of an adult manual transit wheelchair with a seated occupant
732
Development and Validation of Redeemer’s University Depression Scale (RUDS)
733
Development and validation of regression models to predict monthly heating demand for residential buildings
734
Development and Validation of Resilience Scale in Patients with Cardiovascular and Respiratory Diseases
735
Development and validation of reverse phase HPLC method for determination of ortho and meta isomers in N-methyl fluoxetine oxalate
736
Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: Application to pharmacokinetic studies
737
Development and Validation of Reversed-Phase LC Method for Simultaneous Determination Telmisartan, Amlodipine and Their Degradation Products in Fixed Dose Combination Tablets
738
Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms
739
Development and validation of RP-HPLC method for sildenafil citrate in rat plasma-application to pharmacokinetic studies
740
Development and Validation of RPHPLC Method for Simultaneous Estimation of Three Components in cream formulation used in Hemorrhoids Disease
741
Development and validation of RP-HPLC method for simultaneous quantification of the anticancer agents, nilotinib and sorafenib: Application in In-vitro analysis
742
Development and validation of RP-HPLC method for the quantitative estimation of αs1-genetic variants in goat milk
743
Development and Validation of RP-HPLC-UV Method for Determination of Diclofenac Sodium Residues on Surfaces for Cleaning Validation
744
Development and validation of scales to measure organisational features of acute hospital wards Original Research Article
745
Development and validation of screening and confirmatory methods for the detection of chloramphenicol and chloramphenicol glucuronide using SPR biosensor and liquid chromatography–tandem mass spectrometry Original Research Article
746
Development and validation of sensitive and selective LC–MS/MS methods for the determination of BMS-708163, a γ-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions
747
Development and validation of sensitive liquid chromatography/tandem mass spectrometry method for quantification of bendamustine in mouse brain tissue
748
Development and validation of simultaneous estimation method for curcumin and piperine by RP-UFLC
749
Development and validation of sinkhole susceptibility models in mantled karst settings. A case study from the Ebro valley evaporite karst (NE Spain)
750
Development and Validation of Smoking Abstinence Self-efficacy Scale among Iranian Female Adolescents
751
Development and Validation of Social Cognitive Theory Based Questionnaire for Physical Activity to Preventing Osteoporosis (PAQ-SCT)
752
Development and Validation of Social Intelligence Scale for University Students
753
Development and validation of species-specific primers that provide a molecular diagnostic for virus-vector longidorid nematodes and related species in German viticulture
754
DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETERIC METHOD FOR SIMULTANEOUS DETERMINATION OF SIMVASTATIN AND EZETIMIBE IN TABLET FORMULATIONS
755
Development and Validation of Spectrophotometric Method for Simultaneous Estimation of Perindopril and Indapamide in Combined Dosage Form by Simultaneous Equation Method
756
Development and Validation of Stability Indicating HPLC Method for the Determination of Process and Degradation Related Impurities in Telmisartan Drug Substance
757
Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Determination of Selected Drugs Using Green Assessment in Bulk and Pharmaceutical Dosage Form
758
Development and validation of stability indicating TLC densitometric and spectrophotometric methods for determination of Clobetasol propionate
759
Development and validation of stability-indicating high performance liquid chromatography method to analyze gatifloxacin in bulk drug and pharmaceutical preparations
760
Development and Validation of Stability-Indicating HPTLC Method for Mirabegron with Identification, and Characterization of Degradant by ESI-MS
761
Development and validation of stability-indicating UPLC method for the determination of lafutidine and its impurities in bulk and pharmaceutical dosage form
762
Development and validation of static simulation model for CO2 heat pump
763
Development and Validation of Sustainable Aquaculture Indicators: Case of Alborz Dam Basin, Mazandaran, Iran
764
Development and validation of system design principles for water reuse systems Original Research Article
765
Development and Validation of Teacher Emotional Support Scale: a structural equation modeling approach
766
Development and Validation of the “Treatment Satisfaction with Traditional Medicines” Questionnaire (TSTMQ)
767
Development and validation of the alcohol-related God locus of control scale
768
Development and validation of the anger rumination scale
769
Development and validation of the Arabic allergic rhinitis quality of life questionnaire
770
Development and validation of the Basic Empathy Scale
771
Development And Validation Of The Brain Fag Propensity Scale
772
Development and Validation of the Childrenʹs Voice Handicap Index-10 (CVHI-10)
773
Development and validation of the Chinese version of the Diabetes Management Self-efficacy Scale
774
Development and validation of the cognitive stability index, a Web-based protocol for monitoring change in cognitive function
775
Development and validation of the Combined Emotional and Affective Temperament Scale (CEATS): Towards a brief self-rated instrument
776
Development and Validation of the Criminal Aptitude Inventory (Urdu): A Comprehensive Assessment Across Convicted Prisoners and the General Population
777
Development and validation of the Drug-Taking Confidence Questionnaire: A measure of coping self-efficacy
778
Development and Validation of the Ethical Behavior Intention Scale for Medical Students Based on the Theory of Planned Behavior
779
Development and Validation of the Faculty Members’ Academic Optimism Inventory (FMAOI)
780
Development and validation of the Family Decision-Making Self-Efficacy Scale
781
Development and validation of the first high performance-lateral flow immunoassay (HP-LFIA) for the rapid screening of domoic acid from shellfish extracts
782
Development and Validation of the First Iranian Questionnaire to Assess Quality of Life in Patients With Heart Failure: IHF-QoL
783
Development and validation of the frozen soil parameterization scheme in Common Land Model
784
Development and Validation of the Health Literacy Scale for Workers
785
Development and validation of the high performance liquid chromatography–ion exclusion method for detection of lactic acid in milk
786
Development and validation of the hospitality emotional labor scale
787
Development and validation of the humanitarian aid workers resilience scale (HAWRS)
788
Development and Validation of the Immediate Postpartum Care Adherence Questionnaire: An Application of the Theory of Planned Behavior among Healthcare Professionals
789
Development and validation of the Infant Feeding Style Questionnaire
790
Development and validation of the Information Seeking Anxiety scale
791
Development and Validation of the Inviting Teaching Effectiveness Scale based on the Invitational Theory
792
Development and Validation of the Kabaddi Offensive and Defensive Observational Instrument
793
Development and Validation of the Knowledge and Clinical Reasoning of Acute Asthma Management in Emergency Department (K-CRAMED)
794
Development and validation of the low-carbon literacy scale among practitioners in the Taiwanese tourism industry
795
Development and validation of the multidimensional vaginal penetration disorder questionnaire (MVPDQ) for assessment of lifelong vaginismus in a sample of Iranian women
796
Development and Validation of the Occupational Therapy Engagement Scale for Patients with Stroke
797
Development and validation of the ontario acute myocardial infarction mortality prediction rules
798
Development and Validation of the Perception of Labor Pain Questionnaire among Iranian Women
799
Development and validation of the perioperative recovery scale for integrative medicine
800
Development and Validation of the Persian Version of the Acceptable Noise Level (ANL) Test in Normal Children Aged 5-8 Years
801
Development and Validation of the Persian Version of the MNREAD Acuity Chart
802
Development and Validation of the Piri-Muridi Scale
803
Development and validation of the Preschool Temperament Classification System for use with teachers
804
Development and validation of the salespeople forced choice behavioral style test in the information technology industry
805
Development and Validation of the Situational Self-Awareness Scale
806
Development and Validation of the Social Responsibility Questionnaire for Iranian Nurses
807
Development and validation of the Specific Loss of Interest and Pleasure Scale (SLIPS)
808
DEVELOPMENT AND VALIDATION OF THE STUDY CIRCLE MODEL IN HIGHER EDUCATION: THE APPLICATION OF STRUCTURAL EQUATION MODELING
809
Development and Validation of the Teacher-Student Relationship Inventory Using Exploratory and Confirmatory Factor Analysis
810
Development and validation of the technology adoption propensity (TAP) index
811
Development and validation of the thought control ability questionnaire
812
Development and validation of the three-dimensional dynamic code—KIKO3D
813
Development and validation of the Turkish version of the MNREAD visual acuity charts
814
Development and validation of the volatile correction model for PM10 – An empirical method for adjusting TEOM measurements for their loss of volatile particulate matter
815
Development and validation of the workplace bullying scale EAPA-T
816
Development and Validation of Three Novel UV Spectrophotometric Methods for Simultaneous Estimation of Efonidipine Hydrochloride Ethanolate and Telmisartan in Their Synthetic Mixture and Its Comparison Using ANOVA
817
Development and validation of two chromatographic methods for the simultaneous determination of raubasine and almitrine besmesylate in pharmaceutical dosage form
818
Development and validation of two fish-based indices of biotic integrity for assessing perennial coolwater streams in Wisconsin, USA
819
Development and validation of two liquid chromatography–tandem mass spectrometry methods for the determination of silibinin and silibinin hemisuccinate in human plasma
820
Development and validation of two new sensitive ELISAs for Hesperetin and Naringenin in biological fluids
821
Development and validation of UHPLC–ESI-MS/MS method for the determination of selected cardiovascular drugs, polyphenols and their metabolites in human urine
822
Development and validation of ultra high performance liquid chromatography–mass spectrometry method for LBH589 in mouse plasma and tissues
823
Development and Validation of University Teacher’s Evaluation Scale
824
Development and Validation of UV Spectrophotometric Method for Determination of Milnacipran in bulk and Pharmaceutical Dosage Form
825
DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF NAPROXEN IN BULK AND SEMI-SOLID FORMULATION
826
Development and Validation of UV-Spectroscopic First Order Derivative Method for Simultaneous Estimation of Rosuvastatin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture
827
Development and Validation of UV-Visible Spectrophotometric Method for Simultaneous Determination of Eperisone and Paracetamol in Solid Dosage Form
828
Development and Validation of Vierordt’s and Absorbance Ratio Spectrophotometric Methods for Simultaneous Estimation of Aspirin and Omeprazole in Their Binary Mixture
829
Development and Validation of Voltammetric Method for Quantitation of New Antiviral Drug Triazavirin using Bare Carbon Screen-Printed Electrodes
830
DEVELOPMENT AND VALIDATION OF WORD RECOGNITION AND SPELLING TEST FOR THE PURPOSE OF DYSLEXIA ASSESSMENT: A PILOT STUDY
831
Development and validation of work permit system performance assessment questionnaire, a case study in an Iranian oil refinery
832
Development and validation status of the IFMIF High Flux Test Module
833
Development and validation strategies for qualitative spot tests: application to nitrite control in waters Original Research Article
834
Development and validity data of the Brazilian Internet Study on Temperament and Psychopathology (BRAINSTEP)
835
Development and validity of an instrumented handbike: Initial results of propulsion kinetics
836
Development and validity of drinking pattern classification: Binge, episodic, sporadic, and steady drinkers in treatment for alcohol problems
837
Development and Validity of Krik patrick’s Evaluation Tool to Investiagte the Efficincy of the Training Course on Workers use of Hearing Protection Equipment
838
Development and validity of the Patient-centred COPD Questionnaire (PCQ)
839
Development and Validity of the Persian Handwriting Assessment Tool for Primary School-Aged Children
840
Development and Validity of the School Interim Competency of Performance Skill Battery Scale (SICPSBS)
841
Development and verification for analysis of pesticides in eggs and egg products using QuEChERS and LC–MS/MS
842
Development and verification of a 3-D integrated surface water–groundwater model
843
Development and verification of a computer model for thermal distortions in hard turning
844
Development and verification of a coupled DSMC–NS scheme using unstructured mesh
845
Development and verification of a decision support system for the selection of optimum water reuse schemes Original Research Article
846
Development and verification of a generic framework for conceptual design
847
Development and verification of a mathematical model for variations of the specific surface area of mineral powders during intensive milling
848
Development and verification of a meso-scale based dynamic material model for plain-woven single-ply ballistic fabric
849
Development and verification of a nodal approach for solving the multigroup SP3 equations
850
Development and verification of a non-linear disaggregation method (NL-DisTrad) to downscale MODIS land surface temperature to the spatial scale of Landsat thermal data to estimate evapotranspiration
851
Development and verification of a screening model for surface spreading of petroleum
852
Development and verification of a toxicokinetic model of polychlorinated biphenyl elimination in persons working in a contaminated building Original Research Article
853
Development and verification of deep-water blowout models
854
Development and verification of fuel burn-up calculation model in a reduced reactor geometry
855
Development and verification of general correlations for pressure drop and heat transfer in single-phase turbulent flow in enhanced tubes
856
Development and verification of new evaluation indicators for chemical management in corporations to meet WSSD goals
857
Development and verification of remote research environment based on “Fusion research grid”
858
Development and verification of the coupled 3D neutron kinetics/thermal-hydraulics code DYN3D-HTR for the simulation of transients in block-type HTGR
859
Development and viability of a translocated beaver Castor fiber population in The Netherlands Original Research Article
860
Development and viability of bovine preplacentation embryos treated with swainsonine in vitro
861
Development and vulnerability: new perspectives for anxiety disorders
862
Development Arrested. Race, Power and the Blues in the Mississippi Delta: Clyde Woods (1998) London and New York: Verso, i-x and 342pp. Cloth ISBN 1-85984-811-7
863
Development as a Cause in Developmental Disorders: (Commentary on "Control and Cross-Domain Mental Computation: Evidence from Language Breakdown" by William Frawley)
864
Development as a dynamic system
865
Development Assistance for Education Post-2015
866
Development Assistance, Strategic Interests, and the China Factor in Japan’s Role in ASEAN Integration
867
Development banking
868
Development Behavior for Post-Tensioned Self-Centering Steel Connection under Cyclic Loading
869
Development Binary Search Algorithm
870
Development challenges of the business sector as a catalyst for the development of small towns: An empirical study of Besut, Terengganu
871
Development challenges under the Clean Development Mechanism (CDM)—Can renewable energy initiatives be put in place before peak oil?
872
Development Chances of Distributed Energy Production on Small Scale
873
Development characteristics of corrugation at different passing speeds
874
Development characteristics of low oil saturation reservoirs
875
Development Children 4.0 concept for information security of school-age children based on wearable technology
876
Development Comic Based Problem Solving in Geometry
877
Development considerations of DSP-controlled PWM VSC-based STATCOM
878
Development context and ease of use of three programs for self-registration of unemployed people
879
Development Control in Post-Reform China: the Case of Liuhua Lake Park, Guangzhou
880
Development Control on Urban Road Reserves in Kenya: A Case Study on Compliance with Planning Standards
881
Development control, planning incentive and urban redevelopment: evaluation of a two-tier plot ratio system in Hong Kong
882
Development costs of a computer-generated tailored intervention
883
Development dilemma and path choice of coal worker villages from the perspectives of sustainability
884
Development economics and policy: a conference to celebrate the 85th birthday of H.W. Singer
885
Development Economics and Policy: Edited by David Sapsford and John-ren Chen, 1998, MacMillan (Houndmills and London) and St. Martinʹs (New York), pp. 1–569, i–xiii, US price $79.95
886
Development economics: Debraj Ray, Princeton: Princeton University Press, 1998, Hardcover, 848 pp., ISBN: 0691017069
887
Development Effort in Speculative Real Estate Competitions
888
Development finance as institution building: A new approach to poverty-oriented banking : Jan Pieter Krahnen and Reinhard H. Schmidt, Westview Press, Boulder, USA, 1994, 145 pp., US $45.00, ISBN 0-8133-2457-2
889
Development for a 610MPa Class Q&T High Strength Steel Plate B610E for Large Oil Storage Tanks Original Research Article
890
Development for the electric utilities networks towards the national information infrastructure
891
Development framework approach to heterogeneous system design for control systems
892
Development genetic analysis of general cognitive ability from 1 to 12 years in a sample of adoptees, biological siblings, and twins
893
Development goal of 30 GW for China’s biomass power generation: Will it be achieved?
894
Development Hough transform to detect straight lines using pre-processing filter
895
DEVELOPMENT HOUSE INCUBATOR UNIT OPERATED WITH RENEWABLE ENERGY
896
DEVELOPMENT HOUSE INCUBATOR UNIT OPERATED WITH RENEWABLE ENERGY
897
Development impact of Malaysian ecotourism as perceived by the local public: The case of Bakau, Seri Manjung, Perak
898
Development implications of colonial land and human settlement schemes in Cameroon
899
Development implications of demographic trends and projections for an arid region: the case of the Badia Research and Development Project area of Jordan
900
Development implications of demographic trends and projections for an arid region: the case of the Badia Research and Development Project area of Jordan
901
Development implications of demographic trends and projections for an arid region:: the case of the Badia Research and Development Project area of Jordan
902
Development in (X–eX) spectrometer for coincident measurement of the Compton scattered photon and recoil electron
903
Development in (X–eX) spectrometer for coincident measurement of the Compton scattered photon and recoil electron
904
Development in context: the timely emergence of eco-devo
905
Development in Fujian: A county-level perspective
906
Development in Immunoprophylaxis against Rabies for Animals and Humans
907
Development in Indo-Israel Defence Relations Since 9/11: Pakistan’s Security Concern and Policy Options
908
Development in Information and Communications Technology (ICT) Statistics at the Australian Bureau of Statistics
909
Development in Information Society as Reflected in the Online Abstracts of The Information Society (1983–2000)
910
Development in modeling submicron particle formation in two phases flow of solvent-supercritical antisolvent emulsion
911
Development in Motion: Helper T Cells at Work
912
Development in myofibrillar water distribution of two pork qualities during 10-month freezer storage
913
Development in North East Peopleʹs Republic of China: An analysis of enterprise performance 1995–2002
914
Development in situ for Gratings Recorded in Photoresist
915
Development in synthesis and electrochemical properties of thienyl derivatives of carbazole
916
Development in the area of UV-crosslinkable solvent-based pressure-sensitive adhesives with excellent shrinkage resistance
917
Development in the green synthesis of cyclic carbonate from carbon dioxide using ionic liquids
918
Development in the treatment of burns in South America during the last decades
919
Development in the Upper Mississippi Basin: 10 years after the Great Flood of 1993
920
Development index and the challenges of adopting artificial intelligence in improving the quality of e-government services to citizens in Jordan
921
Development Induced Displacement: Issues of Compensation and Resettlement – Experiences from the Narmada Valley and Sardar Sarovar Project
922
Development itself is the key to understanding developmental disorders
923
Development Journalism: State versus Practitioner Perspectives in Indonesia
924
Development Journalism: State versus Practitioner Perspectives in Indonesia
925
Development journey and outlook of Chinese giant oilfields
926
Development length of FRP straight rebars
927
Development Length of Laminar Magnetohydrodynamics Pipe Flows
928
Development length of sinusoidally pulsating laminar pipe flows in moderate and high Reynolds number regimes
929
Development matK Gene as DNA Barcode to Assess Evolutionary Relationship of Important Tropical Forest Tree Genus Mangifera (Anacardiaceae) in Indonesia and Thailand
930
Development mechanism of local plastic buckling in bars subjected to axial impact
931
Development microeconomics: Pranab K. Bardhan and C. Udry, 1999, Clarendon Press: Oxford, pp. 237
932
Development model for energy crop plantations in the Czech Republic for the years 2008–2030
933
Development Model for Supply Chain Network Design by Demand Uncertainty and Mode Selection
934
Development Model of Basic Technique Skills Training Shot-Put Obrien Style Based Biomechanics Review
935
DEVELOPMENT MODEL OF PATISSERIE PROJECT-BASED LEARNING
936
development model training shooting based on multiple unit offense for basketball athletes 16-18 years of age groups
937
Development modeling of presentable services in rural ICT centers in Qom province, Iran.
938
Development Models for the Filth Fly ParasitoidsSpalangia gemina, S. cameroni,andMuscidifurax raptor(Hymenoptera: Pteromalidae) under Constant and Variable Temperatures
939
Development moratoria
940
Development narratives and the uses of ecology: malaria control in Northwest Argentina, 1890–1940
941
Development of Double-Chambered Right Ventricle After Repair of Tetralogy of Fallot
942
DEVELOPMENT OF MULTIMEDIA PROGRAMS TO IMPROVE THE QUALITY AND EFFICIENCY OF DISTANCE LEARNING
943
Development of (2-bromo-1,1,2,2-tetrafluoroethyl)(phenyl)sulfane as tetrafluoroethyl-radical and tetrafluoroethylene-diradical synthons for additions to alkenes
944
Development of (Cr,Al)ON coatings using middle frequency magnetron sputtering and investigations on tribological behavior against polymers
945
Development of [11C]L-159,884: A radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging
946
Development of [201Tl](III)oxinate complex for in vitro cell labeling
947
Development of [60] fullerene supported on silica catalysts for the photo-oxidation of alkenes Original Research Article
948
Development of ^166Ho-zoledronate as a bone marrow ablative agent
949
Development of ‘Pad Element’ for detailed core deformation analyses and its verification Original Research Article
950
Development of ‘timescapesʹ to effectively manage global inter-organizational relational communications
951
Development of “hot” executive function: The children’s gambling task
952
Development of “Macroscopic Composition Gradient Method” and its application to the phase transformation
953
Development of “one-pot” method for multi-class compounds in porcine formula feed by multi-function impurity adsorption cleaning followed ultra-performance liquid chromatography–tandem mass spectrometry detection
954
Development of “stainless” aluminum alloys by surface modification
955
Development of “stainless” aluminum alloys by surface modification
956
Development of “tuned microwave absorbers” using U-type hexaferrite
957
Development of 1 K-class mechanical cooler for SPICA Original Research Article
958
Development of 1 kW class polymer electrolyte membrane fuel cell power generation system
959
Development of 1 kW class solid oxide fuel cell stack using anode-supported planar cells
960
Development of 1 kW h class lithium ion battery for power storage
961
Development of 1 kWh (300 Ah) class lithium-ion battery
962
Development of 1 kW SOFC power package for dual-fuel operation
963
Development of 1 MeV accelerator and HV bushing at JAEA toward ITER Neutral Beam system
964
Development of 1-(2-pyridylazo)-2-naphthol-modified polymeric membranes for the effective batch pre-concentration and determination of zinc traces with flame atomic absorption spectrometry
965
Development of 1,1′-oxalyldiimidazole chemiluminescent biosensor using the combination of graphene oxide and hairpin aptamer and its application
966
Development of 1,2,4-Triazole-5-Thione Derivatives as Potential Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) in Tuberculosis.
967
Development of 10 kA Bi2212 conductor for fusion application
968
Development of 10 kW-scale hydrogen generator using chemical hydride
969
Development of 10 Wh class lithium secondary cells in the ‘New Sunshine Program’
970
Development of 100% lattice match buffer layers on RABiTS Ni tapes by sol-gel
971
Development of 10-kWe preferential oxidation system for fuel cell vehicles
972
Development of 10-V Josephson series arrays
973
Development of 111In-labeled porphyrins for SPECT imaging
974
Development of 116 kDa Fraction for Detecting Experimental Toxoplasma gondii Infections in Mice.
975
Development of 12.5 m2 solar collector panel for solar heating plants
976
Development of 14 MeV neutron spectrometer for fusion experimental reactor
977
Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex
978
Development of 153Sm-DTPA-SPION as a theranostic dual contrast agents in SPECT/MRI
979
Development of 15-m-long radiation hard periscope for ITER in-vessel viewing
980
Development of 16S rRNA Targeted PCR Method for the Detection of Escherichia coli in Rainbow Trout (Oncorhynchus mykiss)
981
Development of 170 GHz/1 MW Russian gyrotron for ITER
982
Development of 177Lu-phytate Complex for Radiosynovectomy
983
Development of 1a and 3a HCV genotyping based on 5´-UTR region by hybridization probe Real--time-PCR
984
Development of 1D model for the analysis of heat transport in cylindrical micro combustors
985
Development of 2 cm-square Hamamatsu avalanche photodiodes for high-resolution X-rays and -rays detection
986
Development of 2 cm-square Hamamatsu avalanche photodiodes for high-resolution X-rays and -rays detection
987
Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists
988
Development of 2,3-diazabicyclo[2.2.1]heptane as a constrained azapeptide template and its uses in peptidomimetic studies
989
Development of 2-acetylpyridine-4-phenyl-3-thiosemicarbazone functionalized polymeric resin for the preconcentration of metal ions prior to their ultratrace determinations by MIS-FAAS
990
Development of 2D and 3D Hi-Nicalon fibres/SiC matrix composites manufactured by a combined CVI–PIP route
991
Development of 2nd prototype of novel silicon Stripixel detector for PHENIX upgrade
992
Development of 2nd prototype of novel silicon Stripixel detector for PHENIX upgrade
993
Development of 2-tbutyl-N-methyl pyrimidones as potent inhibitors of HIV integrase
994
Development of 3 DOF Ultrasonic Vibration Tool for Elliptical Vibration Cutting of Sculptured Surfaces
995
Development of 3 kW at 325 MHz solid-state RF power amplifier using four power amplifier modules
996
Development of 3 kW at 325 MHz solid-state RF power amplifier using four power amplifier modules
997
Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists Original Research Article
998
Development of 30 Watt high-power LEDs vapor chamber-based plate
999
Development of 300 °C heat resistant boron-loaded resin for neutron shielding
1000
Development of 316L(N)-IG stainless steel fabrication approaches for ITER divertor and limiter applications1
